The Journal of Immunology, Vol 155, Issue 6 3152-3160, Copyright © 1995 by American Association of Immunologists

ARTICLES

Differential expression of complement receptors on human basophils and mast cells. Evidence for mast cell heterogeneity and CD88/C5aR expression on skin mast cells

W Fureder, H Agis, M Willheim, HC Bankl, U Maier, K Kishi, MR Muller, K Czerwenka, T Radaszkiewicz and JH Butterfield
Department of Internal Medicine, University of Vienna, Austria.

Complement-dependent activation of immune cells is regulated by cell surface membrane receptors. In this study, expression of complement receptors (CR) on human blood basophils (n = 11), tissue mast cells (lung, n = 7; skin, n = 10; uterus, n = 4; tonsil, n = 3; heart, n = 10), and on respective human cell lines (basophil line KU-812, mast cell line HMC-1) was analyzed by the use of mAbs and indirect immunofluorescence. Normal blood basophils and KU-812 cells were found to express C5aR (CD88), membrane cofactor protein (CD46), decay- accelerating factor (CD55), and membrane attack complex inhibitory factor (CD59), as well as the previously recognized CR1 (CD35), CR3 alpha (CD11b), CR4 alpha (CD11c), and CR3/4 beta (CD18). Mast cells from all organs as well as HMC-1 cells expressed CD46, CD55, and CD59, but not CD11b, CD21, or CD35. The C5aR (CD88) was detectable on skin mast cells, a subset (5 to 15%) of cardiac mast cells, and on HMC-1 cells, but not on lung, uterus, or tonsillar mast cells (< 5%). Moreover, double immunoperoxidase staining (tryptase vs C5aR/CD88) revealed in situ expression of C5aR on skin, but not lung mast cells. Recombinant human (rh) C5a, at 10(-10) to 10(-7) M, induced secretion of histamine from basophils (rhC5a, 10(-8) M: 53.4 +/- 3.1% vs control < 5%) and from skin mast cells (rhC5a, 10(-8) M: 25.8 +/- 16.1% vs control < 10% histamine release), but not from other mast cells (rhC5a or control: < 10%, p > 0.05). The rhC5a-induced secretion of histamine from basophils and skin mast cells was inhibited by S5/1, a blocking Ab against CD88 (basophils: 37.2% to 75.1%; skin mast cells: 39.2% to 83.9% inhibition, p < 0.05). Together, this study shows that a) basophils and mast cells express a different profile of complement receptors, b) C5a-dependent mediator release in skin mast cells and basophils is mediated via CD88, and c) mast cells constitute a heterogenous lineage in terms of expression of the C5a binding site CD88.

This article has been cited by other articles:

				M. Kneidinger, U. Schmidt, U. Rix, K. V. Gleixner, A. Vales, C. Baumgartner, C. Lupinek, M. Weghofer, K. L. Bennett, H. Herrmann, et al. The effects of dasatinib on IgE receptor-dependent activation and histamine release in human basophils Blood, March 15, 2008; 111(6): 3097 - 3107. [Abstract] [Full Text] [PDF]

				S. C. Mullaly and P. Kubes The Role of TLR2 In Vivo following Challenge with Staphylococcus aureus and Prototypic Ligands J. Immunol., December 1, 2006; 177(11): 8154 - 8163. [Abstract] [Full Text] [PDF]

				A. K. Zaidi, Y. Amrani, R. A. Panettieri, and H. Ali Response to C3a, mast cells, and asthma FASEB J, February 1, 2006; 20(2): 199 - 199. [Full Text] [PDF]

				P. Bradding C3a, mast cells, and asthma FASEB J, October 1, 2005; 19(12): 1585 - 1585. [Full Text] [PDF]

				C. Feng, A. G. Mery, E. M. Beller, C. Favot, and J. A. Boyce Adenine Nucleotides Inhibit Cytokine Generation by Human Mast Cells through a Gs-Coupled Receptor J. Immunol., December 15, 2004; 173(12): 7539 - 7547. [Abstract] [Full Text] [PDF]

				A. de Paulis, N. Montuori, N. Prevete, I. Fiorentino, F. W. Rossi, V. Visconte, G. Rossi, G. Marone, and P. Ragno Urokinase Induces Basophil Chemotaxis through a Urokinase Receptor Epitope That Is an Endogenous Ligand for Formyl Peptide Receptor-Like 1 and -Like 2 J. Immunol., November 1, 2004; 173(9): 5739 - 5748. [Abstract] [Full Text] [PDF]

				J. Godau, T. Heller, H. Hawlisch, M. Trappe, E. Howells, J. Best, J. Zwirner, J. S. Verbeek, P. M. Hogarth, C. Gerard, et al. C5a Initiates the Inflammatory Cascade in Immune Complex Peritonitis J. Immunol., September 1, 2004; 173(5): 3437 - 3445. [Abstract] [Full Text] [PDF]

				M. Otto, H. Hawlisch, P. N. Monk, M. Muller, A. Klos, C. L. Karp, and J. Kohl C5a Mutants Are Potent Antagonists of the C5a Receptor (CD88) and of C5L2: POSITION 69 IS THE LOCUS THAT DETERMINES AGONISM OR ANTAGONISM J. Biol. Chem., January 2, 2004; 279(1): 142 - 151. [Abstract] [Full Text] [PDF]

				M. S. Huber-Lang, J. V. Sarma, S. R. McGuire, K. T. Lu, V. A. Padgaonkar, E. M. Younkin, R. F. Guo, C. H. Weber, E. R. Zuiderweg, F. S. Zetoune, et al. Structure-Function Relationships of Human C5a and C5aR J. Immunol., June 15, 2003; 170(12): 6115 - 6124. [Abstract] [Full Text] [PDF]

				D. M. Lee, D. S. Friend, M. F. Gurish, C. Benoist, D. Mathis, and M. B. Brenner Mast Cells: A Cellular Link Between Autoantibodies and Inflammatory Arthritis Science, September 6, 2002; 297(5587): 1689 - 1692. [Abstract] [Full Text] [PDF]

				S.A. Cain, D.M. Williams, V. Harris, and P.N. Monk Selection of novel ligands from a whole-molecule randomly mutated C5a library Protein Eng. Des. Sel., March 1, 2001; 14(3): 189 - 193. [Abstract] [Full Text] [PDF]

				S. M. Drouin, J. Kildsgaard, J. Haviland, J. Zabner, H. P. Jia, P. B. McCray Jr., B. F. Tack, and R. A. Wetsel Expression of the Complement Anaphylatoxin C3a and C5a Receptors on Bronchial Epithelial and Smooth Muscle Cells in Models of Sepsis and Asthma J. Immunol., February 1, 2001; 166(3): 2025 - 2032. [Abstract] [Full Text] [PDF]

				F. H. Falcone, H. Haas, and B. F. Gibbs The human basophil: a new appreciation of its role in immune responses Blood, December 15, 2000; 96(13): 4028 - 4038. [Full Text] [PDF]

				H. Ma and P. T. Kovanen Inhibition of Mast Cell-Dependent Conversion of Cultured Macrophages Into Foam Cells With Antiallergic Drugs Arterioscler. Thromb. Vasc. Biol., December 1, 2000; 20 (12): e134 - e142. [Abstract] [Full Text] [PDF]

				H.-J. Buhring, P. J. Simmons, M. Pudney, R. Muller, D. Jarrossay, A. van Agthoven, M. Willheim, W. Brugger, P. Valent, and L. Kanz The Monoclonal Antibody 97A6 Defines a Novel Surface Antigen Expressed on Human Basophils and Their Multipotent and Unipotent Progenitors Blood, October 1, 1999; 94(7): 2343 - 2356. [Abstract] [Full Text] [PDF]

				B. Settmacher, D. Bock, H. Saad, S. Gartner, C. Rheinheimer, J. Kohl, W. Bautsch, and A. Klos Modulation of C3a Activity: Internalization of the Human C3a Receptor and its Inhibition by C5a J. Immunol., June 15, 1999; 162(12): 7409 - 7416. [Abstract] [Full Text] [PDF]

				L. Escribano, A. Orfao, B. Diaz-Agustin, J. Villarrubia, C. Cervero, A. Lopez, M. A. G. Marcos, C. Bellas, S. Fernandez-Canadas, M. Cuevas, et al. Indolent Systemic Mast Cell Disease in Adults: Immunophenotypic Characterization of Bone Marrow Mast Cells and Its Diagnostic Implications Blood, April 15, 1998; 91(8): 2731 - 2736. [Abstract] [Full Text] [PDF]

				P. Gasque, S. K. Singhrao, J. W. Neal, P. Wang, S. Sayah, M. Fontaine, and B. P. Morgan The Receptor for Complement Anaphylatoxin C3a Is Expressed by Myeloid Cells and Nonmyeloid Cells in Inflamed Human Central Nervous System: Analysis in Multiple Sclerosis and Bacterial Meningitis J. Immunol., April 1, 1998; 160(7): 3543 - 3554. [Abstract] [Full Text] [PDF]

				K. Hartmann, B. M. Henz, S. Kruger-Krasagakes, J. Kohl, R. Burger, S. Guhl, I. Haase, U. Lippert, and T. Zuberbier C3a and C5a Stimulate Chemotaxis of Human Mast Cells Blood, April 15, 1997; 89(8): 2863 - 2870. [Abstract] [Full Text] [PDF]

				N Naik, E Giannini, L Brouchon, and F Boulay Internalization and recycling of the C5a anaphylatoxin receptor: evidence that the agonist-mediated internalization is modulated by phosphorylation of the C-terminal domain J. Cell Sci., January 10, 1997; 110(19): 2381 - 2390. [Abstract] [PDF]